RNA polymerase I inhibitors and uses thereof
Abstract:
Provided are novel compounds which are capable of inhibiting an activity of RNA polymerase I, and uses thereof in treating diseases or disorders modulated by RNA polymerase I, preferably autoimmune diseases such as multiple sclerosis and proliferative diseases.
Public/Granted literature
Information query
Patent Agency Ranking
0/0